Find clinical trials for Lymphoma in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma

Leukemia

Non-Hodgkin Lymphoma

Lymphoid Leukemia

Diffuse Large B-Cell Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma

B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Indianapolis, IN, USA:

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)

on participants who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come back af...

Enrolling

Marginal Zone Lymphoma (MZL)

Relapsed/Refractory Follicular Lymphoma

Drug: Rituximab

Drug: Lenalidomide

Phase 3

Regeneron Pharmaceuticals

Indianapolis, Indiana, United States and 131 other locations

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...

Active, not recruiting

Classic Follicular Lymphoma

Diffuse Large B-Cell Lymphoma

Drug: Epcoritamab

Phase 2

Genmab

Indianapolis, Indiana, United States and 71 other locations

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

treatment of advanced classical Hodgkin lymphoma(HL)...

Active, not recruiting

Hodgkin Lymphoma

Drug: vinblastine

Drug: brentuximab vedotin

Phase 3

Takeda

Indianapolis, Indiana, United States and 215 other locations

Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

the maximum tolerated dose (MTD) of ruxolitinib when given with fixed dose nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma...

Enrolling

Hodgkin Lymphoma

Drug: Ruxolitinib

Drug: Nivolumab

Phase 1, Phase 2

Veronika Bachanova

Indianapolis, Indiana, United States and 4 other locations

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Single arm phase I/II study of ixazomib and romidepsin in relapsed/refractory PTCL. Each cycle is 28 days. Patients will continue to receive therapy...

Active, not recruiting

Lymphoma, T-Cell, Peripheral

Drug: Ixazomib

Drug: Romidepsin

Phase 1, Phase 2

Ryan Wilcox

Indianapolis, Indiana, United States and 6 other locations

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma (OLYMPIA-1)

is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL).This study will be...

Enrolling

Follicular Lymphoma (FL)

Drug: Odronextamab

Drug: Rituximab

Phase 3

Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 150 other locations

Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (BRUIN CLL-321)

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have previously received treatm...

Active, not recruiting

Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia

Drug: Pirtobrutinib

Drug: Bendamustine

Phase 3

Loxo Oncology

Indianapolis, Indiana, United States and 231 other locations

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma (EPCORE FL-1)

Follicular Lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this dise...

Active, not recruiting

Follicular Lymphoma (FL)

Drug: Lenalidomide

Drug: Rituximab

Phase 3

Genmab

Indianapolis, Indiana, United States and 281 other locations

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma (OLYMPIA-3)

The study is focused on patients with diffuse large B-cell lymphoma (DLBCL) that have not been treated before (called "previously untreated"...

Enrolling

Diffuse Large B-cell Lymphoma (DLBCL)

Drug: Doxorubicin

Drug: Prednisone/Prednisolone

Phase 3

Regeneron Pharmaceuticals

Indianapolis, Indiana, United States and 147 other locations

Locations recently updated

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma (OLYMPIA-2)

is focused on participants with previously untreated follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin lymphoma...

Enrolling

Follicular Lymphoma (FL)

Drug: Odronextamab

Drug: Vincristine

Phase 3

Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 94 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Lymphoma in .css-epvm6{white-space:nowrap;}Indianapolis, IN

Related conditions:

Lymphoma trials near Indianapolis, IN, USA:

A Trial to Learn if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma (OLYMPIA-1)

Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (BRUIN CLL-321)

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma (EPCORE FL-1)

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma (OLYMPIA-3)

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma (OLYMPIA-2)

Find clinical trials for Lymphoma in Indianapolis, IN